PEMPHIGUS FOLIACEUS COEXISTING WITH IgA NEPHROPATHY IN A PATIENT WITH PSORIASIS VULGARIS
G. Perez,W. Agger,R. Abellera,P. Dahlberg
DOI: https://doi.org/10.1111/j.1365-4362.1995.tb04400.x
1995-11-01
International Journal of Dermatology
Abstract:A 38-year-old white man vî as referred for evaluation of proteinuria and hematuria. His past medical history was largely unremarkable except for extensive psoriasis vulgaris involving the scalp and the extensor surfaces of the extremities in a typical distribution. One year before the development of renal dysfunction, severe psoriasiform exfoliation had required hospitalization and he had been treated with methotrexate and topical therapy, including corticosteroids, keratolytics, and a tar preparation. He was not receiving any other medications and had no history of prior therapy with penicillamine, phenylbutazone, or rifampin. Routine laboratory testing by his primary care physician revealed a creatinine concentration of 1.4 mg/dL, along with hematuria and proteinuria. Workup at our institution included a renal biopsy that revealed mesangial glomerulonephritis (Fig. 1) with immune deposits of IgA in the mesangium, typical of IgA nephropathy (Fig. 2). Complete blood cell count, total serum protein, and albumin were all within normal limits. Within 2 months of the initial evaluation for renal dysfunction, the patient experienced friable, flaccid bullae, symmetrically distributed over the trunk and arms. Skin blister cultures were sterile. Skin biopsy revealed pemphigus foliaceus. Direct immunofluorescence stains were positive, with widespread intraepidermal deposits of IgG and C3 (Fig. 3). There was very weak antiintercellular space (ics) staining with IgA (not shown) and negative staining for IgM, Ciq, fibrinogen, and albumin. In addition, no staining of the basement membrane zone was found, HLA locus II typing revealed that this patient's cells possessed the following alleles: DR1, DR4, DQw5, and DQw7. Serum studies for indirect immunofluorescence determination of IgG antlICS antibodies were not performed. Currently, he is receiving methotrexate, 2.5 mg orally per day, and topical triamcinolone acetonide ointment. His Berger's disease is